IRMD

iRadimed Corporation

Price

$84.40

return (12m)

18.58%

p/e

46.80

p/bv

10.60

DIVIDEND YIELD

1.50%

IRMD price

iRadimed

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment IRMD

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-8.72%

3 months

-9.32%

1 year

18.58%

2 years

87.62%

5 years

163.55%

10 years

401.09%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals IRMD

Valuation

P/E

46.80

Sector -0.03

Industry 2.50

P/BV

10.60

Sector 1.90

Industry 2.36

P/Revenue (PSR)

12.50

Sector 1.56

Industry 1.83

EV/EBITDA

149.96

Sector -49.34

Industry -3.34

EV/EBIT

159.58

Sector -33.76

Industry -16.52

P/EBITDA

36.97

Sector -60.21

Industry -72.22

P/EBIT

39.16

Sector -58.76

Industry -65.82

P/Total Assets

9.38

Sector 0.90

Industry 1.06

P/Net Current Assets

14.68

Sector -23.35

Industry -5.85

P/Working Capital

13.91

Sector -4.31

Industry 1.60

EPS

1.80

Sector -0.74

Industry -0.59

BVPS

7.96

Sector 3.96

Industry 4.78

Efficiency

Gross Margin

75.86%

Sector 48.49%

Industry 50.04%

EBITDA Margin

33.23%

Sector -313.26%

Industry -57.18%

EBIT Margin

31.23%

Sector -182.06%

Industry -55.62%

Operating Margin

31.91%

Sector -21.96%

Industry -26.59%

Net Profit Margins

26.70%

Sector -26.08%

Industry -30.03%

Asset Turnover

0.18

Sector 0.13

Industry 0.15

Profitability

ROE

22.66%

Sector -26.91%

Industry -24.28%

ROA

20.05%

Sector -26.05%

Industry -25.14%

ROIC

38.82%

Sector -589.68%

Industry -89.29%

Dividends

Dividend yield

1.50%

Sector -

Industry -

Payout

70.20%

Sector -

Industry -

Debt

Current Ratio

9.46

Sector 1.89

Industry 2.02

Net Debt / EBITDA

-8.69

Sector -21.45

Industry -2.68

Net Debt / EBIT

-9.24

Sector -3.01

Industry -2.00

Net Debt / Equity

-0.58

Sector -0.62

Industry -0.27

Gross Debt / Equity

0.00

Sector 0.11

Industry -0.81

Equity/Assets

0.88

Sector 0.45

Industry 0.47

Liabilities/Assets

0.12

Sector 0.49

Industry 0.51

Growth

5Y Revenue CAGR

15.61%

Sector -

Industry -

5Y Earnings CAGR

19.84%

Sector -

Industry -

Fundamentals IRMD

DRAG THE FRAME TO SEE MORE DATA

FAIR VALUE OF iRadimed ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$84.40

Fair Value

$17.95

Upside Return potential.

-78.73%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
IRMD iRadimed Corporation	$84.40	20.92%	1.50%	46.80	10.60	22.66%	26.70%
ISRG Intuitive Surgical Inc.	$365.46	-17.16%	0.00%	40.98	7.07	17.26%	28.62%
ABT Abbott Laboratories	$109.74	-15.48%	2.25%	35.46	3.76	10.61%	11.65%
MDT Medtronic PLC	$94.56	6.67%	3.04%	22.82	2.36	10.35%	14.02%
BSX Boston Scientific Corp.	$47.77	-55.58%	0.00%	19.32	2.85	14.73%	17.49%
TMDX TransMedics Group Inc.	$87.28	-18.38%	0.00%	19.90	5.83	29.28%	22.69%
RMD ResMed Inc.	$227.28	-14.50%	1.06%	21.68	5.07	23.41%	27.44%
IDXX IDEXX Laboratories Inc.	$532.60	-15.99%	0.00%	36.90	26.08	70.67%	25.03%
COHR Coherent Inc.	$282.72	219.57%	0.00%	118.83	4.88	4.11%	6.85%
PHG Koninklijke Philips NV	$26.02	-0.39%	3.89%	19.20	1.88	9.80%	6.30%
SYK Stryker Corp.	$304.60	-20.60%	1.15%	31.24	4.86	15.55%	14.43%
INMD InMode Ltd.	$14.88	2.52%	0.00%	11.32	1.39	12.32%	20.69%
DXCM DexCom Inc.	$88.42	12.04%	0.00%	33.80	12.89	38.14%	20.12%
EW Edwards Lifesciences Corp.	$89.80	10.56%	0.00%	51.58	4.83	9.36%	15.41%
BDX Becton Dickinson and Company	$187.08	1.64%	2.24%	54.57	2.11	3.86%	6.30%
ALGN Align Technology Inc.	$160.43	21.21%	0.00%	27.43	2.68	9.77%	9.99%
SNN Smith & Nephew PLC	$29.00	-19.70%	2.68%	20.30	4.71	23.22%	9.83%
ZBH Zimmer Biomet Holdings Inc.	$98.67	-5.07%	0.97%	23.50	1.50	6.39%	9.48%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

IRMD Historical Dividends

current DY: 1.50%

5-year average DY: 1.97%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	08/13/2026	08/28/2026	0.20000000
Dividends	05/14/2026	05/29/2026	0.20000000
Dividends	02/20/2026	03/06/2026	0.20000000
Dividends	12/16/2025	12/30/2025	0.50000000
Dividends	11/13/2025	11/25/2025	0.17000000
Dividends	08/15/2025	08/28/2025	0.17000000
Dividends	05/19/2025	05/30/2025	0.17000000
Dividends	02/21/2025	03/05/2025	0.17000000
Dividends	11/14/2024	11/25/2024	0.15000000
Dividends	08/19/2024	08/30/2024	0.15000000
Dividends	05/16/2024	05/30/2024	0.15000000
Dividends	12/20/2023	01/12/2024	0.15000000
Dividends	02/09/2023	02/21/2023	1.05000000
Dividends	02/15/2022	02/24/2022	1.00000000

ABOUT iRadimed

iRadimed Corporation

Average Investor10 user rating

4.0 (7 people)

United States

34 years

Founded: 1992

2014

Time since IPO - 12 years

110

Employees

iRadimed Corporation (United States) is listed on the Nasdaq and has a market capitalization of $1.08 billion, with shareholders equity totaling $101.75 million.

The company employs approximately 110 people and operates in the Health sector, within the Medical Supplies and Equipment industry.

Over the past 12 months, iRadimed Corporation reported $86.34 million in revenue, generating net income of $23.06 million.

Key financial metrics include a P/E ratio of 46.80, a price-to-book (P/B) ratio of 10.60, and a trailing twelve-month dividend yield of 1.50%.

The company trades under the ticker IRMD.

Market cap

$1.08 billion

Net worth

$101.75 million

$101,748,000.00

Assets

$114.98 million

$114,975,000.00

Total Shares Outstanding

12.78 million

12,784,000

Average Daily Trading Volume

$125.71 Thousand

$125,710.12

Sector

Health

Industry

Medical Supplies and Equipment

IRMD

IRMD revenue and profits

Financial Results IRMD

DRAG THE FRAME TO SEE MORE DATA

IRMD cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$97.55 36,39% (12M)

P/E

-0.87

2.73%

ROE

-178.93%

P/BV

1.56

CI - Cigna

$284.57 --4,74% (12M)

P/E

10.92

2.17%

ROE

16.04%

P/BV

1.75

CNC - Centene

$67.74 133,75% (12M)

P/E

-6.55

0.00%

ROE

-22.56%

P/BV

1.48

HUM - Humana

$405.08 33,46% (12M)

P/E

37.56

0.88%

ROE

6.72%

P/BV

2.52

SNY - Sanofi

$44.21 --1,17% (12M)

P/E

4.14

4.00%

ROE

18.43%

P/BV

0.76

LLY - Eli Lilly

$1,146.64 56,34% (12M)

P/E

38.25

0.56%

ROE

P/BV

HCA - HCA Healthcare

$405.39 --3,02% (12M)

P/E

11.38

0.74%

ROE

-244.72%

P/BV

-27.86

NVS - Novartis

$160.29 25,95% (12M)

P/E

23.95

1.94%

ROE

30.39%

P/BV

7.28